AAV2 and Hepatocellular Carcinoma

Human Gene Therapy

Volumn 27, Issue 3, 2016, Pages 211-213

  Nault, Jean Charles ^a,b,c,d   Datta, Shalini ^a,b,c   Imbeaud, Sandrine ^a,b,c   Franconi, Andrea ^a,b,c   Mallet, Maxime ^a,b,c   Couchy, Gabrielle ^a,b,c   Letouzé, Eric ^a,b,c   Pilati, Camilla ^a,b,c   Verret, Benjamin ^a,b   Blanc, Jean Frédéric ^e,f   Balabaud, Charles ^f   Calderaro, Julien ^a,b,c,g   Laurent, Alexis ^g,h   Letexier, Mélanie ⁱ   Bioulac Sage, Paulette ^f,j   Calvo, Fabien ^a,b,c,k   Zucman Rossi, Jessica ^a,b,c,l  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e HÔPITAL SAINT ANDRÉ   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h INSERM U955   (France)

ⁱ IntegraGen   (France)

^j HÔPITAL PELLEGRIN   (France)

^k INSTITUT GUSTAVE ROUSSY   (France)

^l HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS 2; ANTINEOPLASTIC ACTIVITY; CANCER PATIENT; CARCINOGENICITY; CASE CONTROL STUDY; EPSTEIN BARR VIRUS; FOLLOW UP; GENE AMPLIFICATION; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HUMAN; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MERKEL CELL POLYOMAVIRUS; OBSERVATIONAL STUDY; REVIEW; RISK FACTOR; SOMATIC MUTATION; TUMOR GENE; UTERINE CERVIX CARCINOMA; VALIDATION STUDY; VIRAL GENE THERAPY; DEPENDOPARVOVIRUS; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR;

CARCINOMA, HEPATOCELLULAR; DEPENDOVIRUS; HUMANS; LIVER NEOPLASMS; MUTAGENESIS, INSERTIONAL;

EID: 84962081587     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2016.002     Document Type: Review

References (19)

1. Nault JC, Datta S, Imbeaud S, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 2015;47: 1187-1193.
2. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009;458:719-724.
3. Ostrove JM, Duckworth DH, Berns KI. Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology 1981;113:521-533.
4. Mayor HD, Drake S, Stahmann J, et al. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am J Obstet Gynecol 1976;126:100-104.
5. Hermonat PL. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res 1991;51: 3373-3377.
6. Luo J, Luo Y, Sun J, et al. Adeno-associated virusmediated cancer gene therapy: Current status. Cancer Lett 2015;356:347-356.
7. Freitas LB, Tonani de Mattos A, Lima BM, et al. Adeno-associated virus may play a protective role against human papillomavirus-induced cervical lesions independent of HIV serostatus. Int J STD AIDS 2012;23:258-261.
8. Nault JC, Mallet M, Pilati C, et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 2013;4:2218.
9. Sung WK, Zheng H, Li S, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012;44:765-769.
10. Schulze K, Imbeaud S, Letouze E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 2015;47:505-511.
11. Huang FW, Hodis E, Xu MJ, et al. Highly recurrent TERT promoter mutations in human melanoma. Science 2013;339:957-959.
12. Vinagre J, Pinto V, Celestino R, et al. Telomerase promoter mutations in cancer: An emerging molecular biomarker? Virchows Archiv 2014;465: 119-133.
13. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10:878-889.
14. Raab-Traub N. Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2012;2:453-458.
15. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.
16. Donsante A, Miller DG, Li Y, et al. AAV vector integration sites in mouse hepatocellular carcinoma. Science 2007;317:477.
17. Chandler RJ, LaFave MC, Varshney GK, et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. J Clin Invest 2015;125:870-880.
18. Russell DW, Grompe M. Adeno-associated virus finds its disease. Nat Genet 2015;47: 1104-1105.
19. Ding D, Lou X, Hua D, et al. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet 2012;8:e1003065.